Patrick Aisher

Patrick Aisher is a seasoned professional with extensive experience in the investment sector, particularly in biotechnology and pharmaceutical drug discovery projects across Central and Eastern Europe. Currently serving as Director at CEBINA Bridge Capital and SONECT, Aisher also holds positions as an Investor at multiple innovative companies such as Danube Labs and PreComb Therapeutics AG, focusing on translating life sciences research into viable medical solutions. With a strong academic background including an MBA from Heriot-Watt University and advanced certifications in trust management, Aisher combines financial expertise with a commitment to addressing unmet medical needs through strategic investments in cutting-edge technologies.